Clinical Trial Update: Diarrheal Adverse Events in Caucasian Patients With Idiopathic Pulmonary Fibrosis Undergoing Treatment With Nintedanib

View source ↗

Summary

This clinical trial update discusses diarrheal adverse events observed in Caucasian patients with idiopathic pulmonary fibrosis treated with nintedanib.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• OFEV (Nintedanib)

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: IPF | Status: ACTIVE_NOT_RECRUITING